Clinical Trial Update: A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022 [Phase 2]

View source ↗

Summary

A Phase 2 long-term safety study of lersivirine in HIV infection patients who completed prior lersivirine trials has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lersivirine (lersivirine)

Snippet

Sponsor: Pfizer | Conditions: HIV-1 | Phase 2 | Status: TERMINATED | Results posted: 2014-06-09